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Abstract
Objective To assess outcomes of percutaneous transjejunal
biliary intervention (PTJBI) in terms of success and
effectiveness in patients with a Roux-en-Y hepaticojeju-
nostomy for benign biliary strictures and stones.
Methods Clinical and radiographic records of 63 patients
with a Roux-en-Y choledochojejunostomy or hepaticojeju-
nostomy for benign disease who underwent at least one
PTJBI between 1986 and 2007 were reviewed. Effective-
ness was determined by successful access rate, rates of
stricture dilatation and/or stone extraction, morbidity,
complications and hospitalisation.
Results PTJBI was attempted 494 times. Successful access
to the Roux-en-Y was accomplished in 93% of interven-
tions. After access to the Roux-en-Y was granted, all
strictures were effectively dilated. Ninety-seven percent of
extraction attempts of intrahepatic calculi were successful.
The median number of interventions per patient was five.
The median interval between interventions was 51.5 weeks
(range 2.7–1,279.6 weeks). The early complication rate was
3%. Morbidity, measured in terms of cholangitis episodes
was 14%, in 25 out of 63 patients. Mean hospitalisation
was 4.1 nights per year.
Conclusion PTJBI is safe and effective in treating benign
biliary strictures and/or calculi. High success rates and short
hospitalisation periods, together with few complications
make it a well-accepted and integral part of managing
complex biliary problems.
Keywords Roux-en-Y hepatojejunostomy.Dilatation.
Stricture.Calculi.Cholangiography
Introduction
Benign biliary strictures and intrahepatic calculi present
challenges for long-term management [1, 2]. While most
patients are well-managed by either a single surgical or
endoscopic intervention, management by a single approach
may be difficult in patients experiencing recurrent biliary
strictures and/or intrahepatic stones. Recurrent stricturing
following surgical repair has been reported to range
between 5 and 45% [3, 4]. Endoscopic intervention is
frequently not possible following a Roux-en-Y hepaticoje-
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DOI 10.1007/s13244-011-0119-yjunostomy or choledochojejunostomy [5]. Currently, con-
ventional transhepatic radiological techniques for stricture
dilatation or stone removal as an adjunct to surgery are
commonly applied in most hospitals throughout the world.
However, percutaneous transjejunal biliary intervention
(PTJBI), a relatively unfamiliar technique, has shown
promising results, although it has yet to be integrated into
daily practice [6, 7]. Our institution, a hepatobiliary referral
centre, has substantially replaced conventional techniques
with PTJBI for non-transplant benign biliary strictures and
intrahepatic stones. Although many researchers are aware
of this technique, there are only a few large studies reported
to date and even fewer studies report single-institution
experiences with long follow-up periods. The transjejunal
approach uses an efferent or afferent limb of the Roux-en-Y
loop, which is fixed to the peritoneum with the fixation site
marked with surgical clips. Radiological access is provided
to the biliary tree for diagnostic cholangiography, stricture
dilatation and intrahepatic stone clearance [7–12]. A
number of reports describe good initial results with PTJBI
[7, 9–14]; however, they lack long-term follow-ups. The
present study is a descriptive retrospective longitudinal
study and reviews more than two decades of experience
with PTJBI at a single institution, allowing for a more
complete assessment of the role of PTJBI in the manage-
ment of complex biliary problems.
Materials and methods
Study population
Seventy-nine patients with Roux-en-Y hepaticojejunostomies
or choledochojejunostomies resulting from bile duct injuries
or benign biliary diseases were assessed for this investigation.
Data were gathered from case notes and radiological records.
Institutional ethics review board permission was obtained and
individual patient consent was not required.
Patients were examined by one radiologist (22 years of
experience). Diagnostic categories included post-operative
bile duct injuries (11 men, 28 women), primary sclerosing
cholangitis (PSC) (three men, three women), recurrent
pyogenic cholangitis (two men, four women), Caroli’s
disease (three men, four women) and other stricture or
stone aetiologies, namely hydatid disease (two men),
autoimmune sclerosing cholangitis (one man) and intra-
hepatic stone disease (one man, one woman). Patients were
divided into two groups according to their dominant
prognosis. Patients with post-cholecystectomy injuries,
primary sclerosing cholangitis and other benign stricture
diseases [hydatid disease (two) and autoimmune sclerosing
cholangitis (one)] were categorised as the ‘Stricture group’
(48 patients) and patients with recurrent pyogenic chol-
angitis, Caroli’s disease and other intrahepatic stone disease
were labelled the ‘Stone group’ (15 patients). A further
classification based on a modification of the Bismuth
classification was applied to patients with post-
cholecystectomy strictures [15]. There was only one patient
with Bismuth type I injury, so Bismuth types I and II were
grouped together in this analysis. Eighteen patients with
Bismuth type I and II injuries were present, eight type III,
13 type IV and there were no patients with type V injuries.
The follow-up period was defined as the time (weeks)
betweenthe first attempt toaccessthe jejunal loop and the last
procedure, clinical review or death. The number, type and
frequency of biliary interventions per patient were recorded.
Radiological technique
Between January 1986 and December 2007, 63 patients
required percutaneous access to the biliary tree. Sixteen
patients did not require percutaneous access and were
excluded; 15 patients remained asymptomatic with normal
liver-function test results and one patient could not be
located in the follow-up. The Roux loop was surgically
fixed to the abdominal wall in 57 patients (90.5%), and six
patients had unfixed Roux loops constructed at other
centres (Table 1).
PTJBI was performed via the fixed limb (either afferent
or efferent limb) of a Roux-en-Y hepaticojejunostomy
which had been created to repair biliary strictures or bile
duct injuries, or specifically for PTJBI access to treat
strictures or stones.
Table 1 Baseline characteristics
Patient characteristics n %
Gender
Men 25 39.7
Women 38 60.3
Age (years)
Mean 62
Range 32–97
Roux-loop characteristics
Fixed loop 57 90.5
Unfixed loop 6 9.5
Stricture group
Post-cholecystectomy injury 39 62
Primary sclerosing cholangitis 6 9.5
Other 3 5
Stone group
Recurrent pyogenic cholangitis 6 9.5
Caroli’s disease 7 11
Other 2 3
558 Insights Imaging (2011) 2:557–565The efferent limb of the Roux loop was surgically fixed
to the parietal peritoneum in a right anterior location, or the
afferent limb was fixed anteriorly in the central upper
abdomen [7]. Marking surgical clips, sometimes in combi-
nation with prior CT images and/or transjejunal cholangio-
grams provided information about the fixation site for loop
puncture. Unfixed loops were accessed percutaneously with
knowledge of previous CT, CT intravenous cholangiogra-
phy (CT–IVC) or by ‘roadmapping’ with percutaneous
transhepatic cholangiography (PTC) to opacify the Roux
loop. Not all patients had marking clips, as some were
transferred from other institutions or had surgery before the
introduction of this technique.
One radiologist (22 years of experience) performed most
interventions and the rest were performed by other
interventional radiologists on site. Most patients were
treated in the afternoon and observed overnight in hospital.
Before intervention, intravenous broad-spectrum antibiotics
were administered. Four hundred and eighty-eight proce-
dures were performed under conscious sedation (intrave-
nous fentanyl and midazolam), with three patients receiving
a general anaesthetic in accordance with the patients’
wishes (one to three times).
The Roux loop was punctured under fluoroscopic
guidance with a 22-gauge Chiba needle (Cook, Brisbane,
Australia); small volumes of contrast materials were
injected, with the needle position adjusted until opacifica-
tion of the jejunal lumen was achieved. No anchoring
device was required as peritoneal fibrosis provided suffi-
cient anchoring. In some patients, an operatively placed
tube was left in position at the time of biliary-enteric
anastomosis and Roux-loop creation. This provided Roux-
loop access for the first PTJBI 6–8 weeks post-operatively.
A 0.035-inch Amplatz guide-wire (Cook, Brisbane, Aus-
tralia) was inserted into the lumen aided by a Neff, or
occasionally a Cope, introduction set (Cook, Brisbane,
Australia). A biliary manipulation catheter (Cook, Brisbane,
Australia) with a very short distal bend and high torque was
then used with the guidewire to negotiate the bowel lumen.
Upon reaching the anastomosis an Amplatz wire, or
sometimes, a Newton guidewire (Cook, Bloomington, IN,
USA) or hydrophilic guidewire (Terumo, Tokyo, Japan) was
used to cross the anastomosis, the direction being con-
trolled by the catheter (Fig. 1)[ 7]. The tendency of longer
Roux loops to telescope, which occurred in some patients,
was overcome by manipulating the loop so that it coiled on
the catheter. Occasionally, this was maintained by use of an
8- or 10-Fr sheath, particularly when dealing with stone
extractions.
Stricture dilatation was performed in one to three
dilatations, depending on stricture resistance. We used
angioplasty balloon catheters (Cook, Brisbane, Australia)
with a diameter of 4–10 mm (Fig. 1). The adjacent normal
duct diameter determined the diameter of the balloon.
Inflation pressures ranged from 6 to 15 atm [7]. Successful
dilatation was defined as inflation of the balloon across the
stricture achieving balloon inflation and residual lumen of
at least 50% of the adjacent duct diameter. Calculi were
extracted intact or fragmented, and extracted or flushed into
the jejunal loop with a helical wire biliary stone basket and/
or balloon catheter (Cook, Brisbane, Australia) (Fig. 2)[ 7].
Ancillary stone destruction methods were not required.
Follow-up was by clinical review. Most patients under-
went elective dilatations at regular intervals ranging from 3
to 12 months in the absence of clinical symptoms and/or
cholangitis. The intervals between elective dilatations were
based on clinical and radiological observations based on the
severity of stricturing, cholangiographic response to dilata-
tion at intervention and symptom-free intervals. In patients
with calculi, the interval time was based on the complete-
ness of stone clearance at previous intervention and the
presence of clinical cholangitis. Non-elective PTJBI was
performed if patients developed clinical cholangitis or
jaundice. An important measure of morbidity was interval
cholangitis between interventions. CT or CT–IVC was used
to exclude abscesses in the presence of sepsis and to
identify isolated obstructed segments [7].
Statistical analysis
Stata8 (StataCorp, College Station, TX, USA, 1984–2003)
was used for statistical analysis of the data. Categorical data
for different analysis groups were compared using the Chi-
squared test or Fisher’s exact test. Poisson regression
determined the numbers of interventions in the different
analysis groups. We tested for proportions to determine
frequencies of characteristics among different groups of
patients. The Kruskal–Wallis test was applied to test for
differences between the various proportions.
Results
A total of 494 interventions were performed. At least one
percutaneous access to the Roux loop was attempted at
each intervention. The Roux loop was initially successfully
accessed on 425 occasions (86%). This value increased to
459 (93%) after opacification of the Roux loop by PTC
roadmapping. Nine procedures were abandoned as percu-
taneous transjejunal access was still unsuccessful after PTC
roadmapping, and nine other procedures were discontinued
as no stones or strictures appeared at PTC roadmapping and
no further intervention was required. Percutaneous trans-
hepatic intervention was performed on 13 occasions, after
failure of PTJBI, with biliary catheters left in place for
drainage in 11 patients (2%) (eight Stricture group patients
Insights Imaging (2011) 2:557–565 559and three Stone group patients). Four biliary interventions
were through an already existing transhepatic drainage
catheter. In some cases, failure to access the Roux loop was
because of the patient’s obesity, or unclear clip marking, or in
patients with unmarked Roux loops. As the contrast material
is injected to identify the needle position within the loop, after
a number of unsuccessful passes, the field of view may
become obscured and targeting is more difficult. After nine
interventions, a removable plastic stent (Cook, Brisbane,
Australia) was placed in the Roux loop (in six patients). A
permanent metal Wallstent (Boston Scientific, Galway, Ire-
land) wasplacedviathe Rouxloopinone instance ina patient
with Caroli’s disease with secondary duct stricturing, and on
three occasions in a patient with end-stage PSC.
Access to a fixed Roux loop was attempted 455 times
and was successful on 426 occasions (94%) compared with
33 out of 39 attempts (85%) in patients with an unfixed
Roux loop (p=0.031). If an efferent or afferent loop was not
marked with clips, patients underwent CT or CT–IVCs,
choosing the shortest loop which had an anterior location
with safe percutaneous access on the basis of the CT. All
strictures present were dilated successfully and out of 169
interventions for the extraction of one or more calculi in all
patients, 157 attempts (93%) were successful (3% failed
extraction, 2% not extracted and 2% not specified).
The mean time from biliary-enteric anastomosis to the
first radiological intervention was 2.9 years [standard
deviation (SD) 5.4 years]. Patients in the Stricture group
had longer intervals between biliary-enteric anastomosis
and initial intervention than patients in the Stone group
[mean 1.52 years (SD 6.03 years) versus 3.47 years (SD
2.66 years) respectively, p=0.031].
The number of interventions and the interval between
interventions varied considerably between patients, ranging
from 1 to 40 interventions over the follow-up period (mean
7.8 interventions, median 5 interventions, SD 8.3 interven-
tions). The mean interval between interventions was
51.5 weeks (median 30.9 weeks, SD 62.9 weeks) (Table 2).
Patients in the Stone group required fewer interventions on a
yearly basis than patients in the Stricture group (p=0.045).
Fig. 1 Balloon dilatation. Transjejunal cholangiogram showing post-
cholecystectomy bile duct injury (Bismuth III) treated by percutaneous
transjejunal biliary dilatation with three strictures dilated from a single
transjejunal approach. a Pre-angioplasty. b Angioplasty of the left
hepatic duct anastomotic stricture. c, d Angioplasty of the right
anterior hepatic duct anastomotic stricture. e, f Angioplasty of the
right posterior hepatic duct anastomotic stricture. g Post-angioplasty
cholangiogram—bile ducts and anastomoses are incompletely dis-
tended and hence have the appearance of residual stricturing
560 Insights Imaging (2011) 2:557–565For elective interventions the standard duration in
hospital was one night (Fig. 3). Nine admissions included
multiple interventions, such as balloon dilatation or stone
extraction over several days. Longer hospitalisation periods
were usually in association with Roux loop repair/re-
fixation or hepatectomy to treat intrahepatic stones that
proved difficult to treat with PTJBI. The mean hospital-
isation period, calculated in nights per patient per year, was
4.1 (median 2.5 nights, SD 4.6 nights) and was similar
between the different patient subgroups. The mean follow-
up was 7.54 years (median 5.4 years, SD 7.47 years).
The liver-function test data were incomplete and
obtained retrospectively from only 50 patients. Twenty
patients had at least one test result that was abnormal.
S e v e np a t i e n t s( 3 7 % )h a da tl e a s tt w oa b n o r m a lt e s t
results. As the liver-function tests were incomplete, we
did not attempt to correlate abnormal liver function and
rates of (re-)stricturing and the presence of calculi as a
long-term analysis.
Morbidity
Interval cholangitis occurred on 67 occasions (14%). Of all
cholangitis episodes, 41 (62%) were associated with
recurrence of strictures, nine (13%) with recurrent stones
and ten (14%) with concurrent recurrence of strictures and
stones. In seven episodes of interval cholangitis (11%),
neither strictures nor stones were identified at transjejunal
cholangiography. There was no correlation between the
different subgroups and interval cholangitis (Table 3).
Complications
Fourteen procedure-related complications occurred: ery-
thematous reaction (one), post-procedure sepsis (eight),
wound abscess (one), perforation of the Roux loops (three)
and left portal vein punctures followed by haemorrhages
and ascites (one).
The non-procedure-related complications of secondary
biliary cirrhosis (two) and oesophageal varices, are inferred
to be due to secondary biliary cirrhosis (two). One patient
with PSC developed cholangiocarcinoma and one patient
with post-cholecystectomy injury developed hepatocellular
carcinoma. Six patients died between 4.4 months and
6.1 years after the last intervention; causes of death were
hepatic failure (two patients, 5.7 months and 3.8 years after
last intervention), cardiac failure (one patient, 8.5 months
after last intervention), aspiration pneumonia (1 patient,
6.1 years after last intervention) and unknown reasons (two
patients, 4.4 months and 4.7 years after last intervention).
Surgical intervention was required for several reasons:
one patient required fixation of an initially unfixed Roux
Fig. 2 Calculi extraction.
Transjejunal cholangiogram
showing: a post-
cholecystectomy anastomotic
stricture with numerous multi-
segment intrahepatic stones; b-d
PTJBI following stricture bal-
loon dilatation and stone clear-
ance using a combination of
flushing and basket extraction.
a,( b The right hepatic duct; c, d
the left hepatic duct and left
segmental duct
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562 Insights Imaging (2011) 2:557–565loop to facilitate percutaneous access to the biliary tree, six
patients with an initially fixed loop required re-fixation for
more favourable access, and two patients required a second
biliary-enteric anastomosis to the intrahepatic biliary tree
(both were segment five hepaticojejunostomies created to
access and treat intrahepatic segment five stone disease).
An additional three patients had partial liver resections to
treat intrahepatic stone disease.
Discussion
Benign biliary strictures and intrahepatic stone diseases
represent a complex group of patients that present chal-
lenges for successful long-term health management. Cur-
rently, while the preferred treatment for post-operative
biliary strictures remains surgical repair, repeat surgery is
not always possible for recurrent strictures and stones [2].
Endoscopic retrograde cholangiography and stricture dila-
tation is usually limited to common duct strictures and is
dependent on adequate duodenal access [16]. Although
initial results were promising, long-term technical success
rates are still relatively lacking and have been reported to be
as low as 10% [17]. Percutaneous transhepatic biliary
intervention is limited by its inability to access all segments
of the biliary tree in a single puncture and carries significant
morbidity as well as patient discomfort [18, 19]. The
importance of maintaining access to the biliary tree in
patients with complex benign biliary strictures and stones is
evident as stricture recurrence requiring radiological or
surgical re-intervention ranges from 10 to 45% [3, 11, 20–
23]. In fact, results may underestimate the true recurrence
rate as many studies have short follow-up times and
recurrence is unpredictable, sometimes occurring many
years after repair [2, 24–27]. The present series demon-
strates several advantages of PTJBI in terms of successful
access, stone and stricture clearance, frequency of inter-
ventions, short hospitalisation and few complications in
relation to conventional methods of treatment.
In our experience, regular elective intervention at an
early stage provides better clinical and cholangiographic
long-term results rather than performing intervention only
when clinical symptoms develop. The standard practice at
our institution is to undertake more frequent interventions
in the early stage (approximately every 3 months), after
which the interval is lengthened according to the clinical
status and cholangiographic appearances (usually 6-month
intervals), until the patient is clinically and cholangio-
graphically stable over several elective procedures. Our
study is limited in the inability to compare our results of
elective interventions with percutaneous transhepatic or
endoscopic interventions. The most appropriate interval
between interventions is difficult to evaluate based on the
data analysis (and is absent from the literature); in our
clinical practice the interval is based on the severity of
stricturing at initial dilatation and clinical and cholangio-
graphic results following intervention.
High success rates for stone clearance and stricture
dilatation were established in the present series and
compare favourably with transhepatic intervention, report-
ing successful dilatation rates from 67 to 90% [4]. Our
immediate procedure-related complication rate of 3%
(minor and major) differs from rates for similar complica-
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Fig. 3 Number of nights in hospital per intervention in all patients.
Histogram depicting length of hospital stay for biliary intervention
Table 3 Number of episodes of interval cholangitis per patient grouped by diagnosis
Episodes of interval cholangitis
Diagnosis No. of patients Total no. of
interventions
Total no. of episodes (%) Mean episodes
per patient
Median (range)
Post-cholecystectomy injury 39 272 42 (15%) 1.1 0 (0–7)
Primary sclerosing cholangitis 6 90 10 (11%) 1.7 1.5 (0–5)
Recurrent pyogenic cholangitis 6 39 2 (5%) 0.3 0 (0–1)
Caroli’s disease 7 73 11 (15%) 1.6 1 (0–5)
Other 5 20 2 (10%) 0.4 0 (0–2)
Total 63 494 67 (14%) 1.1 (p>0.05)
Insights Imaging (2011) 2:557–565 563tions in transhepatic intervention (14.5–23.5%) and endo-
scopic treatment (9–40%) [28–31]. Three patients had
perforation of the Roux loop; this resulted from over-
vigorous dilatation of the percutaneous track in our early
experience using co-axial dilators to allow insertion of a
working sheath of 14–16Fr. Patients underwent surgical
repair of the perforated Roux loop; there were no deaths or
major surgical complications following surgical repair.
Subsequent to this event, however, sheath diameters were
limited to 10–12Fr.
There is some variation in the frequency of interventions
within the different groups. Patients in the Stone group had
longer intervals between interventions than other patients
(p=0.016), which was also exemplified in the number of
interventions on a yearly basis (p=0.045). Additionally,
patients with PSC underwent more frequent dilatations than
the post-cholecystectomy injury group on the basis that the
disease is more likely to be progressive, as well as our
clinical impression that this resulted in better health in the
intervals. Of the post-cholecystectomy patients, Bismuth
types III and IV injuries had greater need for accessing the
Roux loop for subsequent interventions. This is consistent
with findings by Al-Ghnaniem and Benjamin [8], and also
parallels the common experience of poorer surgical out-
comes with higher Bismuth grade strictures or injuries [32].
Currently no definitive treatment to combat the recur-
rence of strictures and calculi exists. Whilst there are no
hard data to establish that preventive intervention in
asymptomatic patients is beneficial, the authors firmly
believe that this is the case for benign strictures with high
risk of recurrence. This is based on the tendency of stricture
dilatation to become progressively more stable after a
number of dilatations, particularly with the tighter stric-
tures. Furthermore, some patients became symptomatic
with cholangitis in the month before the planned dilatation
when an attempt was made to increase the interval between
dilatations. A disadvantage of our approach is the need for
regular interventions at 3- to 12-month intervals depending
on the observed recurrence rates and the patient’s clinical
condition. Nevertheless, in our opinion the percutaneous
transjejunal approach is now the best available minimally
invasive intervention available in terms of safety, effective-
ness, patient acceptance and length of hospital stay.
The reported rate of cholangitis in patients with post-
cholecystectomy biliary strictures ranges between 20 and
32% [33, 34]. However, it is not always a reliable indicator
of recurrent biliary obstruction [35, 36]. Our study supports
this view as most of the recurrent strictures were not
associated with cholangitis; 14% of interventions were
preceded by cholangitis. Similarly, the absence of clinical
cholangitis does not indicate the absence of restenosis; most
episodes of strictures and calculi, respectively 86 and 89%,
were not preceded by cholangitis.
Clinical follow-up in terms of regular liver-function tests
was incomplete in some patients. Of the 50 patients who
underwent liver-function tests, only seven patients had two
or more abnormal test results. Additionally, liver cirrhosis
was usually a clinical diagnosis. Liver biopsy to objectivise
biliary fibrosis or cirrhosis was not routine at our
institution, regardless of treatment mode, which prevents
accurate determination of the rate of longer term cirrhosis.
This information, whilst clearly desirable, is however
relatively deficient for long-term outcomes in this complex
group of patients.
Percutaneous transhepatic stricture dilatation is still
utilised for treatment of recurrent strictures with or without
intrahepatic stones. This approach, however, associated
with significant morbidity and discomfort, has a reported
stricture recurrence rate of up to 34% of patients at 3 years,
and requires long-term indwelling percutaneous catheters
for acceptable results [9, 13, 37, 38]. In the present
investigation, catheters were only left in place in the case
of short-term planned repeat interventions (usually in the
same admission) for stone disease, or in the case of purulent
cholangitis, to ensure good immediate drainage. The trans-
jejunal approach eradicates this need for long-term trans-
hepatic catheters, and multiple segments of the biliary tree
can be accessed through a single access route.
To be effective and acceptable as a procedure, PTJBI
should provide the ability to repeatedly access the biliary
tree over a long period for treatment of strictures and
intrahepatic stones. The procedure must have low morbidity
rates, reasonably short periods of hospitalisation, a good
quality of health between interventions and a high level of
patient acceptance. Our experience suggests that PTJBI
performs well in all of these areas and is an invaluable part
of the management of benign biliary strictures and intra-
hepatic stone disease.
Open Access This article is distributed under the terms of the
Creative Commons Attribution Noncommercial License which per-
mits any noncommercial use, distribution, and reproduction in any
medium, provided the original author(s) and source are credited.
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